TGTX Q1 2018 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TGTXTG Therapeutics, Inc.

$5B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$38,000-0.2% YoY

Gross Profit

$38,000100.0% margin

Operating Income

-$42M-109413.2% margin

Net Income

-$42M-109286.8% margin

EPS (Diluted)

$-0.59

QoQ Revenue Growth

-0.2%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$121M

Total Liabilities

$36M

Stockholders' Equity

$85M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38,000	$38,095	-0.2%
Gross Profit	$38,000	$38,095	-0.2%
Operating Income	-$42M	-$28M	-50.3%
Net Income	-$42M	-$28M	-49.8%